Search

Your search keyword '"Balasa, M"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Balasa, M" Remove constraint Author: "Balasa, M"
149 results on '"Balasa, M"'

Search Results

1. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

4. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

5. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

6. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

7. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

8. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

9. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial

10. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

14. 20170. DISMINUCIÓN DE LOS EFECTOS DE LA PRÁCTICA EN LA ENFERMEDAD DE ALZHEIMER PRECLÍNICA: UN ESTUDIO MULTICÉNTRICO, LONGITUDINAL Y DE COHORTES

16. 21116. PROGRESIÓN CLÍNICA Y BIOMARCADORES PRONÓSTICOS EN LA ENFERMEDAD DE ALZHEIMER

17. 20488. CAPACIDAD PREDICTIVA DEL ESTATUS β-AMILOIDE (LCR) DE P-TAU217 PLASMÁTICA: ESTUDIO MULTICÉNTRICO EN CATALUÑA

18. 21121. CAPACIDAD DIAGNÓSTICA Y UTILIDAD CLÍNICA DE P-TAU181 Y P-TAU217 PLASMÁTICOS EN UNA COHORTE DE RECLUTAMIENTO PROSPECTIVO EN UN CENTRO ESPECIALIZADO EN DETERIORO COGNITIVO

20. 20071. LA ASIMETRÍA CEREBRAL EN LA DEMENCIA FRONTOTEMPORAL POR MUTACIÓN EN GRN DISTINGUE ENTRE DOS SÍNDROMES Y PERMITE LA PREDICCIÓN DEL INICIO DE LA ENFERMEDAD

21. 20279. TRIPLETES CAG EN EL GEN HTT Y SU RELACIÓN CON TAUOPATÍAS: EVIDENCIAS NEUROPATOLÓGICAS

22. 20660. METABOLISMO CEREBRAL Y CORRELACIÓN CON MARCADORES DE LCR EN UNA COHORTE CLÍNICA DE DEMENCIA CON CUERPOS DE LEWY

23. Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia

24. Quality of life and the experience of living with early-stage Alzheimer's disease

25. Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat

26. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort

27. Disease-related cortical thinning in presymptomatic granulin mutation carriers

30. Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia

31. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

32. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

33. Clinical applicability of diagnostic biomarkers in early‐onset cognitive impairment

34. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

35. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

36. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

37. Neurofilament light chain: a biomarker for disease onset and survival in genetic frontotemporal dementia

38. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

39. Impact of Biomarkers on Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty

40. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial

41. Neurofilament light chain: a biomarker for genetic frontotemporal dementia

42. Neurofilament light chain: a biomarker for genetic frontotemporal dementia

43. Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion

44. Biomarcadores en sangre para la enfermedad de Alzheimer: posicionamiento y recomendaciones de uso del Grupo de Estudio de Conducta y Demencias de la Sociedad Española de Neurología

49. Clinical features and APOEgenotype of pathologically proven early-onset Alzheimer disease(CME)

50. Increased neurofilament light chain correlates with decreased white matter integrity in presymptomatic and symptomatic granulin carriers

Catalog

Books, media, physical & digital resources